Last reviewed · How we verify

NCT06702644: SERIC-HS

Safety and Efficacy of Remote Ischemic Conditioning in Patients with Chronic Internal Carotid Artery Occlusion Receiving Hybird Surgery: a Pilot, Randomized Controlled Trial

Not yet recruiting NA Last updated 26 November 2024
What this trial tests

NA trial testing Remote ischemic conditioning in Carotid Artery Occlusion in 60 participants. Not yet recruiting.

Timeline
1 December 2024
Primary endpoint
30 November 2026
31 March 2027

Quick facts

Lead sponsorYi Yang
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment60
Start date1 December 2024
Primary completion30 November 2026
Estimated completion31 March 2027

Drugs / interventions tested

Conditions studied

Sponsor

Yi Yang — full company profile →

Who can join

18 and older, any sex, with Carotid Artery Occlusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to explore the safety and efficacy of remote ischemic conditioning in patients with internal carotid artery occlusion receiving hybird surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Remote ischemic conditioning

Trials testing the same drug.

Other Yi Yang trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06702644.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing